Medulloblastoma

Medulloblastoma

FACTS

#1 most common pediatric brain malignancy
  • WHO grade IV
  • embryonal tumor
  • typical location: cerebellum (in vermis near apex of roof of 4th ventricle) + dorsal brainstem
  • BOARDS: sonic hedgehog gene (SHH) mutations cause medulloblastoma (along with holoprosencephaly). Other frequently associated mutations are in the genes MYCN, CDK6, CTNNB1, and WNT.

CONSULT


HPI

usual presenting sx: HA, n/v, ataxia
infants: irritability, lethargy, macrocrania
Drop mets ROS: back pain, urinary retention, leg weakness
Associated with Fanconi Anemia

FOCUSED EXAM

truncal and appendicular ataxia
nystagmus
EOM palsies
head size (infants)

IMG

MRI Brain w/wo = enhancing midline in children (lateral in adults more likely), T2 = heterogenous (cysts, vessels, Ca2+)
MR spectrography: high Chol, low NAA
  • ependymomas vs. medulloblastomas
  • ependymoma = floor
  • medulloblastomas = roof

A/P
At the time of consult

MRI pan neuro axis w/wo to evaluate for drop mets
Optho c/s for papilledema
Neuro-oncology c/s
3 Pronged Approach to Treatment
Surgical debulking: better to reave last remnant in the brainstem
Radiation: exact fractions will vary based on risk stratification (molecular diagnosis)
Chemotherapy: options include cisplatin, lomustine, vincristine, cyclophosphamide, cyclophosphamide, etoposide, high dose IV MTX/intrathecal MTX Of mafosfamide or intraventricular methotrexate
LP post-op for CSF cytology
Counsel: this is a life changing diagnosis, careful and appropriate delivery to family is important.
  • post-op cerebellar mutism is a common complication in cerebellar tumors for children (up to 53% in medulloblastomas). Risk factors include midline location, brainstem involvement (Greenberg)
  • 30-40% will require permanent VP shunt
  • there is a risk of tumor spread with surgery
  • long-term survivors have high risk of endocrine/cognitive sequalae from treatments
  • poor predictors of prognosis: younger age (<3 years), disseminated disease, inability to perform GTR, poor KPS
 

Classification

Histologic criteria

1. classic
2. desmoplastic / nodular (Nevoid Basal Cell Carcinoma, Gorlin Syndrome)
3. extensive nodularity

Molecular criteria

WNT-activated
SHH-activated (TP53 WT vs. mutant)

Pathology

Figure 1: Homer Wright rosettes (neuroblastoma, medulloblastomas, PNETs) = halos of cells surrounding a neuropil containing central region
Rosette
Description
Pathology
Homer-Wright
halo of tumor cells surrounding centril neuropoil
medullo, neuroblastoma, PNET
Flexner-Wintersteiner
tumor cells surrounding central lumen of cytoplasmic extensions
retinoblastoma
True Ependymal rosette
tumors surrounding empty lumen
Ependymoma (not seen in every case)
Perivascular pseudorosette
tumor cells around blood vessels
Ependymoma > medulloblastoma, PNET, neuroblastoma
notion image

Associations

Figure 1: Holoprosencephaly and medulloblastoma share a connection: both involve mutations in SHH gene
notion image